BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38730433)

  • 1. PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells.
    Moghbeli M
    Cancer Cell Int; 2024 May; 24(1):165. PubMed ID: 38730433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression.
    Maharati A; Moghbeli M
    J Transl Med; 2023 Aug; 21(1):556. PubMed ID: 37596669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells.
    Maharati A; Moghbeli M
    Cell Commun Signal; 2023 Aug; 21(1):201. PubMed ID: 37580737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells.
    Navaei ZN; Khalili-Tanha G; Zangouei AS; Abbaszadegan MR; Moghbeli M
    Oncol Res; 2021; 29(4):235-250. PubMed ID: 37303943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis.
    Peng F; Xu Q; Jing X; Chi X; Zhang Z; Meng X; Liu X; Yan J; Liu X; Shao S
    FASEB Bioadv; 2023 Jun; 5(6):233-250. PubMed ID: 37287867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells.
    Mahmoudian RA; Akhlaghipour I; Lotfi M; Shahidsales S; Moghbeli M
    Pathol Res Pract; 2023 May; 245():154472. PubMed ID: 37087995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
    Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
    Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer.
    Alharbi KS; Shaikh MAJ; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Imam SS; Alshehri S; Ghoneim MM; Singh SK; Chellappan DK; Oliver BG; Dua K; Gupta G
    J Environ Pathol Toxicol Oncol; 2022; 41(4):85-102. PubMed ID: 36374963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beginning of GPX2 and 30 years later.
    Esworthy RS; Doroshow JH; Chu FF
    Free Radic Biol Med; 2022 Aug; 188():419-433. PubMed ID: 35803440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma.
    Yiminniyaze R; Zhang X; Zhu N; Wang J; Li C; Wumaier G; Zhou D; Li J; Xia J; Zhang Y; Dong L; Zhang Y; Li S
    Cancer Med; 2023 Jan; 12(2):1630-1642. PubMed ID: 35770949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells.
    Maharati A; Zanguei AS; Khalili-Tanha G; Moghbeli M
    Cell Commun Signal; 2022 Mar; 20(1):27. PubMed ID: 35264191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview.
    Hamidi AA; Khalili-Tanha G; Nasrpour Navaei Z; Moghbeli M
    Cancer Cell Int; 2022 Feb; 22(1):71. PubMed ID: 35144601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway.
    Liao H; Ding M; Zhou N; Yang Y; Chen L
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35029291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway.
    Lin LL; Yang F; Zhang DH; Hu C; Yang S; Chen XQ
    Cancer Cell Int; 2021 Jun; 21(1):320. PubMed ID: 34174897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity.
    Song X; Jiao X; Yan H; Yu L; Jiang L; Zhang M; Chen L; Ju M; Wang L; Wei Q; Zhao L; Wei M
    Front Cell Dev Biol; 2021; 9():622018. PubMed ID: 34150744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus-mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial-mesenchymal transition in lung adenocarcinoma A549 cells.
    Hu CS; Huang JH; Yang DL; Xu C; Xu ZG; Tan HB; Chen ZZ
    Oncol Lett; 2021 Jun; 21(6):433. PubMed ID: 33868471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer.
    Khandelwal A; Sharma U; Barwal TS; Seam RK; Gupta M; Rana MK; Vasquez KM; Jain A
    Front Oncol; 2021; 11():645475. PubMed ID: 33833996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC
    Yu H; Tian L; Yang L; Liu S; Wang S; Gong J
    Front Oncol; 2021; 11():620213. PubMed ID: 33816250
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.